When Ayurveda Meets the Multivitamin Aisle: Inside MuscleBlaze StrongHer

A conventional women’s multivitamin usually follows a recognisable formula.

It combines nutrients such as:

• • Iron
• • Calcium
• • Zinc
• • Vitamin D
• • Vitamin B12
• • Folic acid
• • Vitamin C
• • Other B vitamins

The product may then be positioned around energy, immunity, bone health or general nutritional support.

In India, some brands go considerably further.

MuscleBlaze StrongHer Women Multivitamin combines familiar vitamins and minerals with a mixture of botanicals drawn from different medical and supplement traditions:

• • Ashwagandha
• • Shatavari
• • Renuka beej
• • Black cohosh
• • Ginger
• • Panax ginseng
• • Additional antioxidant ingredients

MuscleBlaze markets these ingredients through four broad systems:

• • Vitamins and minerals
• • Energy support
• • Antioxidant support
• • A so-called “Hormonal Blend”

The result is not simply a multivitamin with one fashionable herbal ingredient added.

It is a hybrid product that attempts to combine:

• • Modern nutrient-reference values
• • Ayurvedic ingredient familiarity
• • Western herbal-supplement trends
• • Sports-nutrition positioning
• • Women-specific benefit language

That formulation strategy remains less common in mainstream Western multivitamins, where botanical ingredients and essential nutrients are often sold as separate products.

But the combination also creates an evidence challenge.

Each herb has its own:

• • Species
• • Plant part
• • Extraction method
• • Dose
• • standardisation level
• • Clinical evidence
• • Safety profile

Putting several of them inside one tablet does not automatically reproduce the results found in trials of individual standardized extracts.

This is one signal from the Consensys Innovation Signals Engine, which continuously scans a library of more than one million products worldwide for emerging shifts in formulation, positioning and consumer demand.

StrongHer genuinely combines vitamins with named botanicals

MuscleBlaze describes StrongHer as a women’s multivitamin containing 26 vitamins and minerals alongside natural ingredients including:

• • Renuka beej
• • Shatawar or shatavari
• • Ashwagandha
• • Black cohosh
• • Ginger
• • Ginseng
• • Beetroot
• • Grape-derived antioxidant ingredients

The company positions the formula around energy, stamina, antioxidants and women’s hormonal wellbeing.

This is commercially distinctive because the product can appeal simultaneously to consumers seeking:

• • Daily nutritional coverage
• • Fitness and exercise support
• • Traditional herbal familiarity
• • Women-specific positioning
• • Stress and energy support

It is not a purely Ayurvedic formula

The original finding describes StrongHer as standard Western vitamin science blended with Ayurvedic botanicals.

That is broadly correct but incomplete.

Ayurvedic or Indian traditional ingredients

• • Ashwagandha
• • Shatavari
• • Renuka beej, depending on the botanical identity intended
• • Ginger

International herbal-supplement ingredients

• • Black cohosh, traditionally associated with Indigenous North American use and modern menopause supplements
• • Panax ginseng, associated primarily with East Asian traditional medicine

Conventional nutrition ingredients

• • Vitamins
• • Minerals
• • Calcium compounds
• • Iron
• • Zinc
• • B vitamins
• • Antioxidant nutrients

The formula is therefore better described as:

A multi-tradition women’s supplement combining conventional micronutrients with Ayurvedic, North American and East Asian botanicals.

The multivitamin component answers one type of need

Vitamins and minerals have defined nutritional roles.

Examples include:

• • Iron contributes to normal red-blood-cell formation.
• • Vitamin B12 participates in neurological and blood-cell functions.
• • Calcium supports bone structure.
• • Vitamin D contributes to calcium metabolism.
• • Zinc participates in immune and enzymatic processes.
• • B vitamins contribute to normal energy metabolism.

These nutrients can be measured against established intake recommendations.

That makes the conventional part of the formula comparatively easy to communicate:

• • Amount per serving
• • Percentage of recommended intake
• • Nutritional function
• • Deficiency risk

The botanical section is more difficult.

Herbs are not usually evaluated simply by comparing their milligram weight with a universal daily requirement.

Botanical names alone do not tell consumers what they are receiving

A label saying ashwagandha or shatavari does not provide enough information to predict whether a study applies.

Relevant variables include:

• • Botanical species
• • Root, leaf, seed or whole-plant material
• • Extract versus raw powder
• • Extraction solvent
• • Concentration ratio
• • Active-constituent standardisation
• • Daily dose
• • Duration of use
• • Product stability

Two products can both list ashwagandha while delivering chemically different materials.

Research reviews repeatedly note that ashwagandha studies use varied root powders, root extracts and root-plus-leaf extracts at different doses.

For a combination product, the crucial question is not only:

Is ashwagandha included?

It is:

Which extract is included, at what dose, and does that dose match the evidence?

StrongHer does not make its botanical evidence easy to audit

Public product pages identify the botanical blend but do not clearly present a complete, easily auditable breakdown of the amount of every botanical in a serving.

Without individual doses, it is difficult to determine whether the product contains quantities comparable with clinical trials.

This creates several possibilities:

• • A botanical may be present at a clinically studied dose.
• • It may be included primarily for formulation storytelling.
• • Several ingredients may share a relatively small proprietary blend.
• • The extract may differ from the one used in published research.

A long ingredient list can appear comprehensive while making product-specific substantiation harder.

Ashwagandha has the strongest modern evidence base in the blend

Ashwagandha—Withania somnifera is one of the most extensively studied Ayurvedic botanicals.

Clinical research has investigated potential effects involving:

• • Perceived stress
• • Anxiety symptoms
• • Sleep
• • Physical performance
• • Fatigue
• • Cognitive outcomes
• • Hormonal and metabolic markers

Reviews generally find promising evidence for stress and sleep, but they also identify important weaknesses:

• • Small studies
• • Short durations
• • Different extracts
• • Different doses
• • Industry funding
• • Inconsistent outcome measures
• • Limited long-term safety data

A review of clinical trials found that several studies reported reduced anxiety or stress, but many had unclear or high risk of bias.

The responsible conclusion is not:

Ashwagandha has been proven to balance women’s hormones.

It is:

Certain standardized ashwagandha extracts have shown potential benefits for stress and sleep in small human trials, but results cannot automatically be transferred to every product containing the plant.

Ashwagandha is not automatically appropriate for every woman

Ashwagandha can affect biological systems beyond general wellbeing.

Research and clinical guidance have raised considerations involving:

• • Thyroid function
• • Sedation
• • Gastrointestinal effects
• • Medication interactions
• • Autoimmune conditions
• • Rare reports of liver injury
• • Pregnancy and breastfeeding

The formula’s women-focused positioning should not be interpreted as evidence that every ingredient is suitable during pregnancy or for every hormonal condition.

Consumers with medical conditions or taking medication require professional advice rather than relying only on gendered packaging.

Shatavari has a long traditional association with women’s health

Shatavari—Asparagus racemosus is strongly associated with women’s reproductive health in Ayurvedic tradition.

It has traditionally been used in contexts involving:

• • Reproductive wellbeing
• • Lactation
• • Menstrual health
• • Menopausal symptoms
• • General restorative support

Modern clinical evidence is beginning to expand.

A 2025 randomized, double-blind, placebo-controlled trial studied a standardized shatavari root extract in women and reported potential benefits for menopausal symptoms. The trial screened 120 women and randomized 80 eligible participants.

A separate 2026 randomized trial involving women aged 20–40 investigated a standardized extract over 12 weeks and reported outcomes relating to reproductive and stress measures. Seventy participants were randomized and 66 completed the trial.

These studies make shatavari more than a purely traditional claim.

They do not yet create a large, independently replicated evidence base.

Shatavari research remains product-specific and preliminary

The recent trials generally used defined, standardized extracts.

A multivitamin containing an unspecified amount of generic shatavari powder or extract cannot automatically claim the same outcome.

Important unanswered questions include:

• • Does StrongHer use the same plant part?
• • Is its extract standardized?
• • What is the daily dose?
• • Is the dose comparable with the trial?
• • Has the finished StrongHer formula itself been tested?
• • Do the other ingredients alter absorption or tolerability?

This distinction applies throughout the supplement industry.

Evidence for a botanical is not automatically evidence for every multi-ingredient product containing it.

Renuka beej is the least clear ingredient in the formula

The name renuka beej can create botanical ambiguity.

“Beej” means seed, while traditional and commercial terminology may be used inconsistently across products.

Some sources associate renuka or nirgundi terminology with Vitex negundo, although exact identity should be confirmed directly from the manufacturer’s botanical specification.

Research on Vitex negundo is dominated by:

• • Traditional-use descriptions
• • Laboratory studies
• • Animal research
• • Phytochemical analysis
• • Topical or anti-inflammatory applications

A 2024 review concluded that larger randomized clinical trials are still needed to establish safety and efficacy in humans.

StrongHer should publish:

• • Latin botanical name
• • Plant part
• • Extract specification
• • Quantity
• • Intended function

Without that information, “renuka beej” operates more as a traditional ingredient signal than a clearly testable clinical claim.

Similar plant names can create serious evidence errors

Vitex negundo should not be confused with Vitex agnus-castus, commonly called chasteberry.

Chasteberry has been studied for menstrual and premenstrual symptoms.

Vitex negundo is a different species with a different evidence base.

Search results or marketing material can easily transfer research from one Vitex species to another incorrectly.

A credible botanical label should use the full Latin name to reduce this risk.

Black cohosh makes the product more global than Ayurvedic

Black cohosh—Actaea racemosa or Cimicifuga racemosa is native to North America.

It is most commonly marketed for:

• • Hot flushes
• • Night sweats
• • Menopausal discomfort
• • Other vasomotor symptoms

It is not a classical Indian Ayurvedic botanical.

Including it alongside shatavari and ashwagandha shows that MuscleBlaze is selecting ingredients from the global supplement market rather than following one traditional medical system.

This is commercially modern.

It is also scientifically complicated because the ingredients originate from different knowledge systems and are intended for different life stages.

Black cohosh evidence remains inconsistent

Some randomized trials and analyses have reported improvement in menopausal symptoms.

Other reviews have found insufficient or inconsistent evidence.

A 2026 systematic review of non-soy herbal supplements noted that previous reviews found insufficient evidence and that menopause guidance does not consistently recommend black cohosh because results vary across preparations and trials.

A 2024 review similarly found continuing uncertainty around effectiveness and safety.

The plant extract used in one successful study may differ substantially from the material used in another supplement.

StrongHer’s audience appears broader than black cohosh’s best-known use

MuscleBlaze markets StrongHer partly toward active women and gym users.

Black cohosh is most widely associated with menopausal symptom management.

That raises a positioning question:

• • Is the product intended for younger active women?
• • Women experiencing menstrual discomfort?
• • Perimenopausal women?
• • Postmenopausal women?
• • All adult women?

These groups have different needs.

A formula trying to serve all of them risks becoming too broad to substantiate precisely.

Women’s nutritional needs vary substantially by:

• • Age
• • Pregnancy status
• • Menstrual status
• • Diet
• • Health conditions
• • Menopause stage
• • Medication use
• • Physical activity

The phrase “hormonal balance” requires particular caution

Hormones are not one variable that can simply be balanced upward or downward.

The endocrine system includes:

• • Thyroid hormones
• • Insulin
• • Cortisol
• • Estrogen
• • Progesterone
• • Testosterone
• • Pituitary hormones
• • Adrenal hormones

A product claiming to support “hormonal balance” should specify:

• • Which hormone
• • In which population
• • What baseline imbalance
• • What measured outcome
• • Which ingredient
• • At what dose
• • Over what period

Without that detail, the phrase functions more as an appealing wellness concept than a clinically defined endpoint.

The combination may be commercially stronger than it is clinically interpretable

From a marketing perspective, the formula is highly efficient.

One tablet can signal:

• • Complete nutrition
• • Energy
• • Ayurveda
• • Adaptogens
• • Female wellness
• • Menopause support
• • Exercise support
• • Antioxidant protection

From a clinical-evidence perspective, that breadth creates difficulty.

If the user feels better, it is unclear which ingredient contributed.

If an adverse effect occurs, it may be difficult to identify the cause.

If no benefit appears, the manufacturer cannot easily determine whether:

• • The dose was too low
• • The wrong extract was used
• • The population was inappropriate
• • The ingredients interacted
• • The claim itself was unsupported

Western multivitamins usually separate these need states

Mainstream Western supplement brands commonly divide these benefits into different products:

• • Women’s daily multivitamin
• • Menopause formula
• • Stress supplement
• • Sleep product
• • Ashwagandha capsule
• • Black-cohosh supplement
• • Sports multivitamin
• • Prenatal vitamin

This allows clearer doses and narrower claims.

The Indian hybrid model compresses several products into one.

The consumer may prefer one familiar, comprehensive product rather than several specialist supplements.

Hybrid formulation is not unique to India—but India makes it more culturally explicit

Western supplements increasingly include:

• • Ashwagandha
• • Turmeric
• • Rhodiola
• • Ginseng
• • Medicinal mushrooms
• • Botanical blends

However, many still present these ingredients through the language of:

• • Adaptogens
• • Stress support
• • Functional wellness
• • Performance
• • Clean-label nutrition

Indian brands can connect the same ingredients more openly to:

• • Ayurveda
• • Traditional use
• • Women’s rasayana concepts
• • Local household familiarity
• • India’s institutional AYUSH framework

A Western label may say:

Clinically studied adaptogen.

An Indian label may say:

Ayurvedic herb traditionally used for women’s vitality.

Himalaya represents a more developed traditional-to-modern model

Himalaya Wellness provides a useful comparison because it has built a large portfolio around the stated combination of Ayurveda and modern science.

The company says its research and development system includes:

• • Botanical identification
• • Standardisation
• • Preclinical research
• • Safety evaluation
• • Clinical studies
• • GMP manufacturing

Himalaya states that its Ayurvedic facility received GMP certification in 2001 and describes itself as an early Indian Ayurvedic facility to receive that status.

Its international product platform describes the company’s approach as combining Ayurvedic knowledge with modern science and technology.

“AYUSH-certified” is an imprecise description

The original research row says Himalaya holds AYUSH certification.

That phrase should be used cautiously.

India’s traditional-medicine regulatory environment includes:

• • Product and manufacturing licences
• • State licensing authorities
• • GMP requirements
• • Pharmacopoeial standards
• • Ministry of AYUSH policies
• • Export documentation
• • Other certifications depending on product type

Ayurvedic, Siddha and Unani medicine manufacturing is regulated under the Drugs and Cosmetics framework, including GMP provisions in Schedule T.

Therefore, a more precise statement is:

Himalaya manufactures Ayurvedic products within India’s AYUSH-regulated system and promotes GMP-certified manufacturing and research capabilities.

A manufacturing licence or GMP certificate does not prove that every product has passed a placebo-controlled trial.

Himalaya does publish product research—but quality varies

Himalaya maintains a research-paper library for products such as Liv.52 and has supported or published numerous clinical and preclinical studies.

Recent peer-reviewed studies continue to investigate Liv.52 in liver-related conditions.

However, the existence of peer-reviewed papers does not mean every study provides equally strong evidence.

Relevant quality questions include:

• • Was the trial randomized?
• • Was it double-blind?
• • Was there a placebo or suitable comparator?
• • Was the sample large enough?
• • Was the endpoint clinically important?
• • Was the study preregistered?
• • Who funded it?
• • Were adverse events fully reported?
• • Has an independent team replicated it?

Traditional knowledge and randomized trials answer different questions

Ayurvedic use can provide information about:

• • Historical applications
• • Preparation traditions
• • Cultural meaning
• • Longstanding patterns of use
• • Practitioner experience

Randomized controlled trials provide a different type of evidence about:

• • Average treatment effect
• • Comparison with placebo
• • Defined dose
• • Defined population
• • Measurable outcome
• • Short-term safety

Neither should be misrepresented.

Traditional use is not the same as clinical proof.

A modern trial does not determine the complete cultural value of a traditional system.

The strongest hybrid product connects all three stages.

Standardisation is the bridge between Ayurveda and modern trials

Traditional preparations can vary naturally.

Modern clinical research requires consistency.

A standardized botanical extract should control variables such as:

• • Species identity
• • Plant part
• • Harvest conditions
• • Extraction process
• • Marker compounds
• • Contaminant limits
• • Batch-to-batch variability

Without standardisation, two studies described as testing the same herb may have used materially different products.

This is where companies such as Himalaya and specialist ingredient suppliers can create defensible intellectual property.

The finished combination needs its own research

Even strong evidence for individual ingredients does not prove that a multi-ingredient supplement works as a complete formula.

The ideal StrongHer study would compare:

• • StrongHer
• • Placebo
• • Possibly a conventional multivitamin without botanicals

It would define:

• • Target female population
• • Botanical doses
• • Primary outcome
• • Secondary outcomes
• • Trial duration
• • Safety monitoring
• • Hormone measurements where relevant
• • Nutrient status
• • Exercise or lifestyle conditions

Without such a study, the product’s evidence remains assembled ingredient by ingredient.

Formulation interactions can matter

Botanical and nutrient ingredients may affect:

• • Absorption
• • metabolism
• • Gastrointestinal tolerance
• • Sedation
• • Thyroid activity
• • Medication effects

For example, a formula combining stimulating and calming botanicals may not produce the simple sum of each ingredient’s advertised benefit.

More ingredients do not automatically mean more benefit.

Women’s supplements need life-stage precision

A more evidence-led portfolio could separate products for:

Menstruating adults

Potential priorities:

• • Iron where appropriate
• • Folate
• • Vitamin D
• • General nutrient coverage

Preconception and pregnancy

Requires carefully designed prenatal nutrition and avoidance of inadequately studied botanicals unless professionally advised.

Perimenopause

Potential focus on vasomotor symptoms, sleep, bone health and clinically relevant nutrient needs.

Postmenopause

Potential focus on bone, cardiovascular health and nutritional adequacy.

Active or athletic women

Potential focus on dietary gaps, iron status, recovery and performance-related nutrition.

“Women” is too broad to function as a precise formulation brief.

Traditional ingredients can create a strong local trust advantage

Indian consumers may already recognise names such as:

• • Ashwagandha
• • Shatavari
• • Ginger
• • Amla
• • Turmeric

That familiarity can reduce the distance between a modern supplement tablet and household wellness traditions.

A product can feel:

• • Scientifically organised
• • Culturally familiar
• • Convenient
• • More holistic than a standard multivitamin

This is a significant commercial advantage over imported formulas built entirely around technical nutrient language.

The model is highly exportable

The hybrid strategy could work in international markets among consumers interested in:

• • Ayurveda
• • Adaptogens
• • Plant-based wellness
• • Women’s health
• • Natural ingredients
• • Preventive nutrition

But export success requires stronger transparency.

International consumers and regulators may expect:

• • Exact ingredient quantities
• • Latin botanical names
• • Standardisation details
• • Third-party testing
• • Heavy-metal limits
• • Clinical substantiation
• • Interaction warnings

Botanical contamination is another important safety layer

Herbal supplements can face risks involving:

• • Incorrect species
• • Adulteration
• • Heavy metals
• • Pesticides
• • Microbial contamination
• • Residual solvents
• • Undeclared pharmaceuticals

A credible hybrid formula needs both:

• • Nutrient testing
• • Botanical identity and purity testing

A multivitamin laboratory programme alone may not be sufficient for a complex herbal blend.

The category needs a better evidence label

Consumers should be able to distinguish between:

Traditional-use ingredient

Included because of historical practice.

Preclinical ingredient

Supported mainly by laboratory or animal data.

Emerging clinical ingredient

Supported by small or early human trials.

Clinically established ingredient for a defined endpoint

Supported by replicated, high-quality human evidence.

Finished-product tested formula

The exact commercial combination has been evaluated.

StrongHer currently presents all botanical names together, which can make their evidence appear equally strong.

They are not.

A comparative evidence matrix shows the difference

Ingredient

Traditional association

Current human evidence

Main limitation

Ashwagandha

Stress, vitality and restorative use

Several small trials and reviews, especially for stress and sleep

Extracts, doses and study quality vary

Shatavari

Women’s reproductive and restorative health

Emerging small randomized trials

Limited replication and product-specific evidence

Renuka beej / possible Vitex negundo

Traditional medicinal use

Very limited strong clinical evidence for women’s outcomes

Botanical identity and dose need clarification

Black cohosh

North American traditional use; modern menopause positioning

Mixed trial and review results

Preparation differences and inconsistent efficacy

Ginger

Digestive and traditional wellness uses

Substantial evidence for some defined outcomes, depending on dose and population

StrongHer-specific dose not clear

Panax ginseng

East Asian vitality and fatigue use

Mixed but meaningful human research for selected outcomes

Extract and dose variability

The strongest claim may be the simplest one

StrongHer can credibly state that it provides a combination of vitamins, minerals and named botanical ingredients.

More ambitious claims—particularly around hormone balancing—need product-specific evidence.

A responsible hierarchy would be:

Directly verifiable

• • Contains listed nutrients and botanicals
• • Provides declared percentages of nutrient intake
• • Uses a hybrid formulation model

Plausible but ingredient-dependent

• • May support stress, energy or women-specific wellbeing

Requires stronger finished-product evidence

• • Corrects hormonal imbalance
• • Produces clinically meaningful reproductive benefits
• • Works for women across all life stages

The real innovation is epistemological

StrongHer does more than combine ingredients.

It combines different ways of deciding what counts as a reason to believe.

Nutrient science says:

The body requires defined vitamins and minerals.

Ayurveda says:

Plants have long-established roles within a wider traditional health system.

Modern phytotherapy says:

Standardized extracts can be tested against defined outcomes.

Sports nutrition says:

The consumer wants energy, stamina and recovery.

The product attempts to hold all four systems inside one tablet.

India may be showing where global supplements are heading

The global supplement market is increasingly moving away from simple vitamin-only products.

Brands are adding:

• • Adaptogens
• • Mushrooms
• • Probiotics
• • Amino acids
• • Herbal extracts
• • Functional ingredients

India starts with a cultural advantage because botanical health traditions are already familiar and institutionally visible.

The opportunity is not merely to add more herbs.

It is to create a higher evidence standard for hybrid products.

That means publishing:

• • Exact doses
• • Botanical species
• • Plant parts
• • Extract ratios
• • Marker compounds
• • Batch-test results
• • Finished-product clinical trials

Ayurveda and modern nutrition are not inherently incompatible

A vitamin and a botanical can coexist in the same formula.

The central issue is not whether the ingredient came from a traditional or Western system.

It is whether the company can explain:

• • Why it is included
• • What form is used
• • How much is present
• • What evidence applies
• • Which consumers were studied
• • What safety controls are in place

The best hybrid supplement would not ask consumers to choose between tradition and science.

It would use modern scientific methods to define exactly where traditional knowledge is supported, where it remains promising and where claims are still uncertain.

MuscleBlaze StrongHer shows the commercial potential of that combination.

It also shows why a long botanical list is only the beginning of the evidence story.

Brand Radar Signal Tags

Brands and Organisations

MuscleBlaze StrongHer Himalaya Wellness Ministry of AYUSH HealthKart Himalaya Research and Development Centre

Products

MuscleBlaze StrongHer Women Multivitamin Himalaya Liv.52 Women’s Multivitamin Ayurvedic Botanical Supplement Hybrid Nutritional Supplement

Vitamins and Minerals

Iron Calcium Zinc Vitamin D Vitamin B12 Folate Vitamin C B Vitamins Micronutrient Adequacy

Botanicals

Ashwagandha Withania somnifera Shatavari Asparagus racemosus Renuka Beej Vitex negundo Black Cohosh Actaea racemosa Ginger Panax Ginseng

Innovation Types

Hybrid Traditional–Modern Formulation Nutrient–Botanical Convergence Cross-Tradition Botanical Assembly Institutionalised Ayurvedic Research Standardised Traditional Botanicals Life-Stage-Specific Hybrid Nutrition Dual Quality-Control System Evidence-Level Ingredient Disclosure

Trust Mechanisms

Ayurvedic Heritage GMP Manufacturing AYUSH-Regulated Production Peer-Reviewed Studies Traditional Use Standardized Extract Recommended Dietary Allowance Founder and Brand Authority

Evidence Signals

Ashwagandha Human Trials Emerging Shatavari RCTs Mixed Black Cohosh Evidence Limited Renuka Beej Clinical Evidence Published Himalaya Research Finished-Product Trial Not Located Individual Botanical Doses Require Disclosure

Market Signals

Indian Women’s Nutrition Adaptogen Mainstreaming Ayurveda in Sports Nutrition Traditional Familiarity in Modern Format Multi-Benefit Combination Product Exportable Indian Wellness Model East–West Formulation Convergence

Risk Signals

Hormonal-Balance Overstatement Women Treated as One Consumer Group Botanical Species Ambiguity Cross-Species Evidence Substitution Proprietary Blend Opacity Ingredient Evidence Applied to Finished Product Botanical–Medication Interaction Pregnancy and Breastfeeding Suitability Contamination and Adulteration Risk

Sources

MuscleBlaze StrongHer formulation

• • MuscleBlaze official product page: Lists StrongHer’s natural ingredients including renuka beej, shatavari, ashwagandha, black cohosh and ginger, and positions them within its women-focused Hormonal Blend. https://www.muscleblaze.com/sv/muscleblaze-strongher-women-multivitamin-for-energy-n-stamina/SP-62147
• • Tata 1mg product listing: Provides a wider ingredient list including vitamins, minerals, Panax ginseng, black cohosh, ginger, ashwagandha, renuka beej and shatavari.
• • Amazon India product description: Describes the four-blend structure and the combination of traditional botanical extracts with conventional nutrient RDAs.

Ashwagandha evidence

• • Mikulska et al., 2023: Reviews modern research on Withania somnifera, including clinical trials involving stress, sleep, immune outcomes and other uses.
• • Sprengel et al., 2025: Reviews ashwagandha’s health and sports evidence and notes that several anxiety studies had unclear or high risk of bias.
• • Wiciński et al., 2025: Critically evaluates evidence involving mood, stress, sleep, fatigue and cognitive outcomes.

Shatavari evidence

• • Mahajan et al., 2025: Randomized, double-blind, placebo-controlled study of standardized shatavari root extract in women.
• • Mhatre et al., 2026: Twelve-week randomized, double-blind, placebo-controlled trial examining reproductive and stress-related outcomes in women aged 20–40.
• • 2026 women’s sexual-wellness trial: Examines a standardized shatavari extract in a prospective randomized controlled design.

Black cohosh evidence

• • Hedaoo et al., 2024: Reviews the efficacy and safety evidence for black cohosh in menopausal symptoms.
• • 2026 systematic review of non-soy herbal supplements: Notes insufficient and inconsistent evidence for black cohosh and differences among commercial preparations.
• • Updated menopause meta-analysis: Reviews randomized evidence while noting continuing uncertainty around adverse effects and efficacy.

Renuka beej and Vitex negundo

• • 2024 Vitex negundo review: Concludes that large, well-designed randomized human trials are still needed to establish efficacy and safety.
• • Review of Vitex negundo traditional uses and pharmacology: Shows that much of the literature remains traditional, phytochemical or preclinical rather than high-quality women-specific clinical research.

Himalaya Wellness and AYUSH regulation

• • Himalaya Research and Development Centre: Describes the company’s research system and its GMP certification history.
• • Himalaya international healthcare portfolio: States that the company combines Ayurveda with modern science, technology and GMP manufacturing.
• • Himalaya research-paper library: Provides product-specific papers for Liv.52 and other formulations.
• • India AYUSH-sector regulatory overview: Explains that Ayurvedic manufacturing is governed through the Drugs and Cosmetics framework and Schedule T GMP provisions.
• • Ministry of AYUSH export-compliance roadmap: Provides official context for licensing, GMP and regulatory documentation rather than a single universal “AYUSH efficacy certificate.”